TR201900735T4 - Yeni kaynaşık imidazobenzotiyazol bileşikleri. - Google Patents
Yeni kaynaşık imidazobenzotiyazol bileşikleri. Download PDFInfo
- Publication number
- TR201900735T4 TR201900735T4 TR2019/00735T TR201900735T TR201900735T4 TR 201900735 T4 TR201900735 T4 TR 201900735T4 TR 2019/00735 T TR2019/00735 T TR 2019/00735T TR 201900735 T TR201900735 T TR 201900735T TR 201900735 T4 TR201900735 T4 TR 201900735T4
- Authority
- TR
- Turkey
- Prior art keywords
- compounds
- new fused
- pharmaceutically acceptable
- fused imidazobenzothiazole
- relates
- Prior art date
Links
- HWAXRLFNEXLBSN-UHFFFAOYSA-N 2h-imidazo[4,5-g][1,3]benzothiazole Chemical class C1=CC2=NCSC2=C2N=CN=C21 HWAXRLFNEXLBSN-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
Mevcut buluş, yeni kaynaşık imidazobenzotiyazol türevleri, bunların farmasötik olarak kabul edilebilir tuzları ve bunların izomerleri, steroizomerleri, atropizomerleri, konformerleri, totomerleri, polimorfları, hidratları, solvatları ve N-oksitleri ile ilgilidir. Mevcut buluş ayrıca, söz konusu bileşiklerin farmasötik olarak kabul edilebilir bileşimleri ve yeni bileşiklerin hazırlanmasına yönelik prosesi kapsar. Buluş ayrıca, farmasötikler olarak kullanıma yönelik ilacın hazırlanmasına yönelik olarak yukarıda geçen bileşiklerin kullanımı ile ilgilidir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1089MU2014 | 2014-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201900735T4 true TR201900735T4 (tr) | 2019-02-21 |
Family
ID=54194050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/00735T TR201900735T4 (tr) | 2014-03-27 | 2015-03-24 | Yeni kaynaşık imidazobenzotiyazol bileşikleri. |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US9908898B2 (tr) |
| EP (1) | EP3122755B1 (tr) |
| JP (1) | JP6480949B2 (tr) |
| KR (1) | KR102339610B1 (tr) |
| CN (1) | CN106414458B (tr) |
| AR (1) | AR099867A1 (tr) |
| AU (1) | AU2015237840B2 (tr) |
| CA (1) | CA2943098C (tr) |
| CY (1) | CY1121147T1 (tr) |
| DK (1) | DK3122755T3 (tr) |
| EA (1) | EA029745B9 (tr) |
| ES (1) | ES2707099T3 (tr) |
| HR (1) | HRP20190121T1 (tr) |
| HU (1) | HUE042493T2 (tr) |
| IL (1) | IL247955B (tr) |
| LT (1) | LT3122755T (tr) |
| MX (1) | MX368985B (tr) |
| MY (1) | MY193041A (tr) |
| PH (1) | PH12016501903A1 (tr) |
| PL (1) | PL3122755T3 (tr) |
| PT (1) | PT3122755T (tr) |
| RS (1) | RS58324B1 (tr) |
| SG (1) | SG11201607793RA (tr) |
| SI (1) | SI3122755T1 (tr) |
| TR (1) | TR201900735T4 (tr) |
| TW (1) | TWI648282B (tr) |
| UA (1) | UA121469C2 (tr) |
| WO (1) | WO2015145336A1 (tr) |
| ZA (1) | ZA201606598B (tr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201802911RA (en) | 2013-03-15 | 2018-05-30 | Global Blood Therapeutics Inc | Compounds and uses thereof for the modulation of hemoglobin |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| TWI648282B (zh) * | 2014-03-27 | 2019-01-21 | 印度商托仁特生技有限公司 | 新熔合咪唑苯并噻唑化合物 |
| DE102016209204A1 (de) | 2016-05-27 | 2017-11-30 | Robert Bosch Gmbh | Vorrichtung zur Regelung mindestens eines Fluidstroms in einem Fahrzeug |
| KR102630959B1 (ko) * | 2016-10-31 | 2024-01-29 | 엘지디스플레이 주식회사 | 유기 화합물과 이를 이용한 발광다이오드 및 유기발광다이오드 표시장치 |
| CN106727538A (zh) * | 2017-02-20 | 2017-05-31 | 潘连香 | 一种治疗2型糖尿病的药物组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8724566D0 (en) * | 1987-10-20 | 1987-11-25 | Roussel Lab Ltd | Chemical compounds |
| GB8908845D0 (en) * | 1989-04-19 | 1989-06-07 | Roussel Lab Ltd | Chemical compounds |
| JPH09512548A (ja) * | 1994-04-29 | 1997-12-16 | ファルマシア・アンド・アップジョン・カンパニー | レトロウイルス感染、特にｈｉｖ感染の治療のためのメタノール誘導体 |
| WO2002014321A1 (en) * | 2000-08-11 | 2002-02-21 | The Regents Of The University Of California | Use of stat-6 inhibitors as therapeutic agents |
| US7601846B2 (en) * | 2001-06-26 | 2009-10-13 | The Regents Of The University Of California | Compounds having activity as inhibitors of apoptosis |
| WO2004048368A2 (en) * | 2002-11-25 | 2004-06-10 | Pharmacia Corporation | Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| GB0320244D0 (en) * | 2003-05-06 | 2003-10-01 | Aventis Pharma Inc | Pyrazoles as inhibitors of tumour necrosis factor |
| EP1984363A1 (en) * | 2006-02-09 | 2008-10-29 | Pfizer Limited | Triazolopyridine compounds |
| TWI648282B (zh) * | 2014-03-27 | 2019-01-21 | 印度商托仁特生技有限公司 | 新熔合咪唑苯并噻唑化合物 |
-
2015
- 2015-03-16 TW TW104108329A patent/TWI648282B/zh active
- 2015-03-24 LT LTEP15717242.0T patent/LT3122755T/lt unknown
- 2015-03-24 UA UAA201610628A patent/UA121469C2/uk unknown
- 2015-03-24 WO PCT/IB2015/052124 patent/WO2015145336A1/en active Application Filing
- 2015-03-24 AU AU2015237840A patent/AU2015237840B2/en not_active Ceased
- 2015-03-24 TR TR2019/00735T patent/TR201900735T4/tr unknown
- 2015-03-24 US US15/128,886 patent/US9908898B2/en active Active
- 2015-03-24 KR KR1020167029134A patent/KR102339610B1/ko active IP Right Grant
- 2015-03-24 JP JP2016559356A patent/JP6480949B2/ja not_active Expired - Fee Related
- 2015-03-24 MX MX2016012535A patent/MX368985B/es active IP Right Grant
- 2015-03-24 ES ES15717242T patent/ES2707099T3/es active Active
- 2015-03-24 CA CA2943098A patent/CA2943098C/en active Active
- 2015-03-24 DK DK15717242.0T patent/DK3122755T3/en active
- 2015-03-24 CN CN201580024068.6A patent/CN106414458B/zh not_active Expired - Fee Related
- 2015-03-24 SG SG11201607793RA patent/SG11201607793RA/en unknown
- 2015-03-24 PL PL15717242T patent/PL3122755T3/pl unknown
- 2015-03-24 EP EP15717242.0A patent/EP3122755B1/en active Active
- 2015-03-24 HU HUE15717242A patent/HUE042493T2/hu unknown
- 2015-03-24 PT PT15717242T patent/PT3122755T/pt unknown
- 2015-03-24 MY MYPI2016703533A patent/MY193041A/en unknown
- 2015-03-24 EA EA201691920A patent/EA029745B9/ru not_active IP Right Cessation
- 2015-03-24 SI SI201530555T patent/SI3122755T1/sl unknown
- 2015-03-24 RS RS20190084A patent/RS58324B1/sr unknown
- 2015-03-27 AR ARP150100915A patent/AR099867A1/es not_active Application Discontinuation
-
2016
- 2016-09-21 IL IL247955A patent/IL247955B/en active IP Right Grant
- 2016-09-23 ZA ZA2016/06598A patent/ZA201606598B/en unknown
- 2016-09-27 PH PH12016501903A patent/PH12016501903A1/en unknown
-
2018
- 2018-01-03 US US15/861,399 patent/US10227361B2/en active Active
-
2019
- 2019-01-21 HR HRP20190121TT patent/HRP20190121T1/hr unknown
- 2019-01-21 CY CY20191100076T patent/CY1121147T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501440A1 (en) | Novel heterocyclic compounds | |
| MX2018011831A (es) | Antagonistas solubles de receptor de c5aa(c5ar). | |
| TR201900735T4 (tr) | Yeni kaynaşık imidazobenzotiyazol bileşikleri. | |
| EA201791256A1 (ru) | Производные хиназолина, применяемые для лечения вич | |
| EA033544B1 (ru) | Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret) | |
| MX2016011992A (es) | Derivados de piperidina-diona. | |
| TW201613567A (en) | Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament | |
| EA201791304A1 (ru) | Производные изохинолина для лечения вич | |
| MY175854A (en) | Novel quinolone derivatives | |
| PH12016500885A1 (en) | Novel heterocyclic compounds | |
| PH12017501830A1 (en) | Novel pyridinium compounds | |
| TW201613864A (en) | Novel compounds | |
| MX2016012451A (es) | Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina. | |
| GEP20207108B (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| NZ731118A (en) | Dopamine d3 receptor antagonists compounds | |
| MX2017000183A (es) | Amidas de benzoxazinona como moduladores del receptor de mineralocorticoides. | |
| MX2017009292A (es) | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3. | |
| PH12018502246A1 (en) | Substituted fused pyrimidinone compounds | |
| MY157629A (en) | Fused thiazolo and oxazolo pyrimidinones | |
| IN2013MU00665A (tr) | ||
| PH12017500323B1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
| PH12016502480A1 (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
| IN2014KO00191A (tr) |